Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Osteoporosis 1Obesity 1Hypertension 1Hypercholesterolemia 1Diabetes Mellitus 1Cushing Syndrome 1Adrenal incidentaloma 1Adrenal Gland Neoplasms 1

Interventions

Metformin 7Exenatide 4Vitamin D 2Sugars 2Resistance Training 2penclomedine 1licogliflozin 1exemestane 1dapagliflozin 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Weight Reduction Programs 1Therapeutics 1Testosterone 1Taxes 1Tamoxifen 1TOPS 1Surveys and Questionnaires 1Sugammadex 1Sodium-Glucose Transporter 2 Inhibitors 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Qsymia 1Progesterone 1Paclitaxel 1Observation 1Nutrition Assessment 1Naltrexone 1Methods 1Letrozole 1Jogging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Obesity × Adrenalectomy × Clear all
NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
4 enrolled 10 charts
EndocrineOther

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡